# US 2026/0183453 A1 · Method for producing a hydrogel comprising a cross-linked silylated polysaccharide

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0183453 A1
- Document ID: US20260183453A1
- Status: Published application
- Kind: A1
- Application number: 18/857,049
- Filed: 2023-04-14
- Published: 2026-07-02
- Earliest claimed: 2022-04-15
- Applicants: Teoxane SA
- Inventors: Jimmy FAIVRE; François BOURDON
- Web page: https://patentgrep.com/patent/US20260183453A1

## CPC

- A61L 27/52: Hydrogels or hydrocolloids
- C08J 3/075: Macromolecular gels
- A61K 8/042: {Gels}
- A61K 8/585: {Organosilicon compounds}
- A61K 8/73: Polysaccharides
- A61K 8/731: {Cellulose; Quaternized cellulose derivatives}
- A61K 8/735: {Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof}
- A61K 8/736: {Chitin; Chitosan; Derivatives thereof}
- A61L 27/20: Polysaccharides
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61Q 19/08: Anti-ageing preparations
- C08B 37/0072: {Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates}
- C08J 3/24: Crosslinking, e.g. vulcanising, of macromolecules (mechanical aspects B29C35/00; crosslinking agents C08K)
- C08L 5/08: Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- A61L 2300/204: with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
- A61L 2300/402: Anaestetics, analgesics, e.g. lidocaine
- C08J 2300/108: containing hydrolysable silane groups
- C08J 2305/08: Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

The present disclosure relates to a process for preparing a hydrogel comprising a crosslinked polysaccharide, in particular, a process for preparing an injectable hydrogel comprising crosslinked hyaluronic acid. The present invention also relates to a hydrogel, preferably an injectable hydrogel, obtainable by the process, a composition comprising the hydrogel, and uses of the hydrogel.

## Claims

### Claim 1

A method for preparing a hydrogel comprising the following steps:
a) providing at least one polysaccharide;
b) providing at least one molecule of formula Chem. I:
or a salt thereof,
wherein:
T represents an isocyanate, amino, epoxide, carboxyl, N-succinimidyloxycarbonyl, N-sulfosuccinimidyloxycarbonyl, halogenocarbonyl, isothiocyanate, vinyl, formyl, hydroxyl, sulfhydryl, hydrazino, acylhydrazino, aminoxy or carbodiimide group, or an acid anhydride residue;
A represents a chemical bond or a spacer group;
R5 and R6, identical or different, represent a hydrogen atom; a halogen atom; an —OR4 group with R4 representing a hydrogen atom, an aryl group or an aliphatic hydrocarbon group having 1 to 6 carbon atoms; an aryl; or an aliphatic hydrocarbon group having 1 to 6 carbon atoms optionally substituted by one or more groups chosen from a halogen atom, an aryl and a hydroxyl;
R10 represents a hydrogen atom, an aryl group or an aliphatic hydrocarbon group having 1 to 6 carbon atoms;
c) functionalisation of the polysaccharide with at least one molecule of formula Chem. I;
d) crosslinking by sol-gel reaction of the functionalised polysaccharide in order to give a hydrogel;
wherein step d) comprises a crosslinking by sol-gel reaction carried out in a reaction medium at a pH greater than or equal to 9 and less than 14, at a pressure P less than or equal to atmospheric pressure and at a temperature T greater than the temperature of the eutectic point of the reaction medium as measured at pressure P and less than the temperature of the freezing point of the reaction medium as measured at pressure P, for a duration t ranging from 2 weeks to 17 weeks, or
wherein step d) comprises a crosslinking by sol-gel reaction carried out in a reaction medium at a pH greater than or equal to 6.8 and less than or equal to 7.8, at a pressure P less than or equal to the atmospheric pressure and at a temperature T greater than the temperature of the eutectic point of the reaction medium as measured at pressure P and less than the temperature of the freezing point of the reaction medium as measured at pressure P, for a duration t between 1 hour and 48 hours.

### Claim 2 (depends on 1)

The method according to claim 1, wherein T is between −55° C. and −5° C.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the polysaccharide is chosen from pectin and pectic substances; chitosan; cellulose and its derivatives; agarose; glycosaminoglycans; and the mixtures thereof.

### Claim 4 (depends on 1)

The method according to claim 1 wherein the polysaccharide is a glycosaminoglycan.

### Claim 5 (depends on 1)

The method according to claim 1 wherein in the molecule of formula Chem. I A is a divalent aliphatic hydrocarbon chain having 1 to 12 carbon atoms, wherein one or more divalent units chosen from the arylenes, —O—, —S—, —S(O)—, —C(═O)—, —SO2— and —N(R9)— are optionally intercalated between two carbon atoms of said chain, with R9 representing a hydrogen atom, an aliphatic hydrocarbon group having 1 to 6 carbon atoms, or an aryl-(C1-C6)alkyl, said chain being non-substituted or substituted by one or more monovalent groups chosen from a halogen atom, a hydroxide, an aryl-(C1-C6)alkyl.

### Claim 6 (depends on 1)

The method according to claim 1 wherein in the molecule of formula Chem. I:
A is a divalent chain —(C1-C6)alkylene-O—(C1-C6)alkylene-;
R5 and R6, identical or different, are each an —OR4 group with R4 representing a (C1-C6)alkyl group; or a (C1-C6)alkyl group, and
R10 is a (C1-C6)alkyl group.

### Claim 7 (depends on 1)

The method according to claim 1, wherein in step c), said polysaccharide is functionalised in the presence of 0.01 to 0.5, moles of molecule of formula Chem. I or a salt thereof, per 1 mole of polysaccharide repetition unit.

### Claim 8 (depends on 1)

The method according to claim 1, wherein steps c) and d) are concomitant or partially concomitant.

### Claim 9 (depends on 1)

The method according to claim 1, further comprising a step e) of crosslinking of the polysaccharide in the presence of at least one crosslinking agent or a salt thereof, said crosslinking agent comprising at least two functional groups Z, identical or different, chosen from the isocyanate, amino, epoxide, carboxyl, N-succinimidyloxycarbonyl, N-sulfosuccinimidyloxycarbonyl, halogenocarbonyl, isothiocyanate, vinyl, formyl, hydroxyl, sulfhydryl, hydrazino, acylhydrazino, aminoxy, carbodiimide groups, and an anhydrous acid residue.

### Claim 10 (depends on 1)

The method according to claim 1, further comprising a step f) of adding a molecule of formula Chem. III: R7O—[R12R13SiO]p—R8
or a salt thereof
wherein:
p is an integer from 1 to 20;
R12 and R13, identical or different, represent a hydrogen atom; a halogen atom; an —OR14 group with R14 representing a hydrogen atom, an aryl group or an aliphatic hydrocarbon group having 1 to 6 carbon atoms; an aryl; or an aliphatic hydrocarbon group having 1 to 6 carbon atoms optionally substituted by one or more groups chosen from a halogen atom, an aryl and a hydroxyl; and
R7 and R8, identical or different, represent a hydrogen atom, an aryl group or an aliphatic hydrocarbon group having 1 to 6 carbon atoms.

### Claim 11 (depends on 1)

The method according to claim 1, further comprising a step j) of sterilising the hydrogel.

### Claim 12 (depends on 1)

The method according to claim 1, further comprising a step g) of adding at least one additional component chosen from lubricants; cosmetic active ingredients such as antioxidants, co-enzymes, amino acids, vitamins, minerals, and nucleic acids; and the mixtures thereof.

### Claim 13 (depends on 1)

The method according to claim 1, comprising the addition of at least one therapeutic active ingredient.

### Claim 14 (depends on 1)

A hydrogel that can be obtained by a method according to claim 1.

### Claim 15 (depends on 14)

A cosmetic or pharmaceutical composition comprising a hydrogel according to claim 14 and a physiologically acceptable excipient.

### Claim 16 (depends on 14)

A method for filling and/or replacing tissues comprising administering to a subject the hydrogel according to claim 14 or a composition comprising the hydrogel of claim 14 and a physiologically acceptable excipient.

### Claim 17 (depends on 14)

An aesthetic method for preventing and/or treating the change in the viscoelastic or biomechanical properties of the skin; for filling volume defects of the skin; for attenuating the nasolabial folds and bitterness folds; for increasing the volume of the cheekbones, the chin or lips; for restoring the volumes of the face, and around the eye; for reducing the appearance of wrinkles and fine lines; or to regenerate, hydrate, firm or restore the radiance of the skin comprising administering to a subject the hydrogel according to claim 14 or a composition comprising the hydrogel according to claim 14 and a physiologically acceptable excipient.

### Claim 18 (depends on 14)

An aesthetic method for the modified delayed or prolonged release of at least one cosmetic active ingredient comprising administering to a subject a hydrogel according to claim 14 or comprising the hydrogel according to claim 14 and a physiologically acceptable excipient, the hydrogel or the composition comprising the at least one cosmetic active ingredient.

### Claim 19 (depends on 4)

The method according to claim 4, wherein the polysaccharide is hyaluronic acid or a salt thereof.

### Claim 20 (depends on 6)

The method according to claim 6, wherein in the molecule of formula Chem. I, T represents an amino or epoxide group.
